These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26413841)

  • 21. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs on demand.
    Nature; 2015 Nov; 527(7579):410. PubMed ID: 26607505
    [No Abstract]   [Full Text] [Related]  

  • 23. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
    Hoerger M
    Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should terminally ill patients have access to phase I drugs?
    Bristol N
    Lancet; 2007 Mar; 369(9564):815-6. PubMed ID: 17366691
    [No Abstract]   [Full Text] [Related]  

  • 25. From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
    Knoepfler PS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():192-6. PubMed ID: 25489841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compassionate use of unauthorized drugs: Legal regulations and ethical challenges.
    Borysowski J; Górski A
    Eur J Intern Med; 2019 Jul; 65():12-16. PubMed ID: 31036436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why are promising new drugs for dying patients still out of reach?
    Peckham C
    MedGenMed; 2007 Jun; 9(2):49. PubMed ID: 17955104
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of Publicly Available Expanded Access Policies.
    Jung E; Zettler PJ; Kesselheim AS
    Clin Pharmacol Ther; 2018 Nov; 104(5):1016-1021. PubMed ID: 29271014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right-to-Try Investigational Therapies for Incurable Disorders.
    Simmons Z
    Continuum (Minneap Minn); 2017 Oct; 23(5, Peripheral Nerve and Motor Neuron Disorders):1451-1457. PubMed ID: 28968371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Food and Drug Administration responds to pressure for expanded drug access.
    Brower V
    J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
    [No Abstract]   [Full Text] [Related]  

  • 31. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
    Puckett A
    SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
    [No Abstract]   [Full Text] [Related]  

  • 32. Has compassionate use ever sunk a drug?
    McAnaw S; Rodriguez CA; Muller A; Mitnick C; Horsburgh CR
    Int J Tuberc Lung Dis; 2018 Feb; 22(2):119-120. PubMed ID: 29506605
    [No Abstract]   [Full Text] [Related]  

  • 33. Ethics versus legal informed consent--a distinction with little difference.
    Zinman EJ
    J Hist Dent; 2007; 55(3):134-8; discussion 171-85. PubMed ID: 18380247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study population selection.
    Treiman DM
    Epilepsy Res Suppl; 1993; 10():125-35. PubMed ID: 8251088
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of the U.S. Food and Drug Administration in device evaluation and monitoring.
    ; Diehl DL; Tierney WM; Adler DG; Conway JD; Farraye FA; Kantsevoy SV; Kaul V; Kethu SR; Kwon RS; Mamula P; Pedrosa MC; Rodriguez SA
    Gastrointest Endosc; 2010 Jul; 72(1):5-10. PubMed ID: 20421100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One Last Shot.
    Berlin J
    Tex Med; 2016 Jul; 112(7):33-8. PubMed ID: 27441422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ethical plausibility of the 'Right To Try' laws.
    Carrieri D; Peccatori FA; Boniolo G
    Crit Rev Oncol Hematol; 2018 Feb; 122():64-71. PubMed ID: 29458791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What compassionate use means for gene therapies.
    Chapman CR; Moch KI; McFadyen A; Kearns L; Watson T; Furlong P; Bateman-House A
    Nat Biotechnol; 2019 Apr; 37(4):352-355. PubMed ID: 30940936
    [No Abstract]   [Full Text] [Related]  

  • 39. Is it time to rethink the expanded-access programs for HIV infection?
    Amorosa V; Tebas P
    J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanded access to Phase II clinical trials in oncology: a step toward increasing scientific validity and compassion.
    Marcee AK
    Food Drug Law J; 2008; 63(2):439-57. PubMed ID: 18561471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.